- Urogynecology
- Urology
- Patient Advocacy
- Hormone Replacement Therapy (HRT)
- Genitourinary Syndrome of Menopause (GSM)
- Health Policy
- Vaginal Estrogen
- Menopause
- OBGYN
Is one outdated warning label standing between millions of women and safe, effective care? In this episode of BackTable Urology, Dr. Yahir Santiago-Lastra, a urologist specializing in female pelvic medicine and reconstructive surgery at UC San Diego, joins host Dr. Suzette Sutherland to discuss the black box warning on vaginal estrogen, its historical context, and the ongoing advocacy efforts to update outdated FDA guidelines
Timestamps
Resources
- (TRAVERSE Trial) Cardiovascular Safety of Testosterone-Replacement Therapy
- Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
- (ASCO Study) Use of local estrogen therapy among breast cancer patients in SEER-MHOS database
- Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks